Morgan Stanley Maintains Equal-Weight on Chubb, Raises Price Target to $360
Morgan Stanley analyst Bob Huang maintains Chubb (NYSE:CB) with a Equal-Weight and raises the price target from $340 to $360.
Read original at benzingaStocks · News reference
Chubb reported in-line Q2 results, but P&C premiums and major account weakness are concerns. Analysts remain neutral to bullish.
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Morgan Stanley analyst Bob Huang maintains Chubb (NYSE:CB) with a Equal-Weight and raises the price target from $340 to $360.
Read original at benzingaBerkshire Hathaway Q2 holdings shows new names and changes to old positions. Here's the list of changes and the top 10 holdings.
Read original at benzingaA member of Congress bought Berkshire Hathaway shares right before Q2 earnings and the stock hitting new 52-week highs.
Read original at benzingaAn official report on August 7, 2026 reveals Representative Maria Elvira Salazar's recent purchase of Berkshire Hathaway Inc. New Common Stock (NYSE:BRK) stock, valued between $46,004 and $165,000. The transaction
Read original at benzingaCigna Healthcare is introducing Smart Coverage, a new benefit option that automatically links medical claims with supplemental benefits to provide eligible members up to $7,000 for covered health events. The program launches January 1, 2027, for mid-sized employers and addresses a significant affordability gap, with nearly 60% of Americans unprepared for health costs. The initiative is designed to increase enrollment in high-deductible plans and boost supplemental product participation.
Read original at zacks-investment-researchBy linking medical and supplemental health benefits, the new solution reduces administrative complexity and helps customers identify and use their available benefits. It also makes it easier to access cash benefits tied
Read original at benzinga